256 related articles for article (PubMed ID: 19784588)
21. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
22. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
23. The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells.
Stuart EC; Rosengren RJ
Life Sci; 2008 Apr; 82(17-18):943-8. PubMed ID: 18371987
[TBL] [Abstract][Full Text] [Related]
24. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
Yamato K; Yamada T; Kizaki M; Ui-Tei K; Natori Y; Fujino M; Nishihara T; Ikeda Y; Nasu Y; Saigo K; Yoshinouchi M
Cancer Gene Ther; 2008 Mar; 15(3):140-53. PubMed ID: 18157144
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells.
Borutinskaite VV; Navakauskiene R; Magnusson KE
Ann N Y Acad Sci; 2006 Dec; 1091():346-55. PubMed ID: 17341627
[TBL] [Abstract][Full Text] [Related]
26. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway.
Wu PP; Kuo SC; Huang WW; Yang JS; Lai KC; Chen HJ; Lin KL; Chiu YJ; Huang LJ; Chung JG
Anticancer Res; 2009 Apr; 29(4):1435-42. PubMed ID: 19414399
[TBL] [Abstract][Full Text] [Related]
27. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
28. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
29. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.
Basu A; Haldar S
Int J Oncol; 2009 Jan; 34(1):281-6. PubMed ID: 19082499
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional responses to epigallocatechin-3 gallate in HT 29 colon carcinoma spheroids.
McLoughlin P; Roengvoraphoj M; Gissel C; Hescheler J; Certa U; Sachinidis A
Genes Cells; 2004 Jul; 9(7):661-9. PubMed ID: 15265009
[TBL] [Abstract][Full Text] [Related]
31. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
32. Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts.
Bae JY; Kanamune J; Han DW; Matsumura K; Hyon SH
Cell Transplant; 2009; 18(4):459-69. PubMed ID: 19622233
[TBL] [Abstract][Full Text] [Related]
33. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Stuart EC; Scandlyn MJ; Rosengren RJ
Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
[TBL] [Abstract][Full Text] [Related]
34. Enhanced antitumor activities of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives in vitro and in vivo.
Matsumura K; Kaihatsu K; Mori S; Cho HH; Kato N; Hyon SH
Biochem Biophys Res Commun; 2008 Dec; 377(4):1118-22. PubMed ID: 18983978
[TBL] [Abstract][Full Text] [Related]
35. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
[TBL] [Abstract][Full Text] [Related]
36. The molecular response of vanadium complexes of nicotinoyl hydrazone in cervical cancers--a possible interference with HPV oncogenic markers.
Nair RS; Kuriakose M; Somasundaram V; Shenoi V; Kurup MR; Srinivas P
Life Sci; 2014 Oct; 116(2):90-7. PubMed ID: 25258113
[TBL] [Abstract][Full Text] [Related]
37. Apoptotic effect of green tea polyphenol (EGCG) on cervical carcinoma cells.
Asif Siddiqui F; Naim M; Islam N
Diagn Cytopathol; 2011 Jul; 39(7):500-4. PubMed ID: 20607746
[TBL] [Abstract][Full Text] [Related]
38. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
Gu B; Ding Q; Xia G; Fang Z
Oncol Rep; 2009 Mar; 21(3):635-40. PubMed ID: 19212621
[TBL] [Abstract][Full Text] [Related]
39. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin-3-O-gallate disrupts stress fibers and the contractile ring by reducing myosin regulatory light chain phosphorylation mediated through the target molecule 67 kDa laminin receptor.
Umeda D; Tachibana H; Yamada K
Biochem Biophys Res Commun; 2005 Jul; 333(2):628-35. PubMed ID: 15946647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]